Joben Bio-Medical Co Ltd is a Taiwan-based company mainly engaged in the development and sale of new plant medicines, local Chinese herbal medicines, health foods and medical beauty products. The Company develops JBM-TC4 plant new drug, which has been patented, used to provide raw materials for cancer treatment drugs.

Employees

Sector

Biotechnology & Medical Research

More about the company

End-of-day quote Taipei Exchange Other stock markets 18/10/2019			5-day change	1st Jan Change
10.50 ^TWD	+0.96%		+8.81%	-

14/19/14	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
15/19/15	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	CI

Market Cap	64Cr 2.04TCr 56Cr 52Cr 48Cr 91Cr 6.04TCr 93Cr 622.43Cr 240.84Cr 2.99TCr 240.6Cr 235.35Cr 10TCr	P/E 2017	53.5x	P/E 2018	-22.8x
Enterprise Value	87Cr 2.77TCr 76Cr 70Cr 66Cr 123.08Cr 8.18TCr 125.64Cr 842.68Cr 326.07Cr 4.04TCr 325.74Cr 318.63Cr 14TCr	EV / Sales 2017	5.87x	EV / Sales 2018	15.8x
Free-Float	82.63%	Yield 2017	0.07%	Yield 2018	-

14/19/14	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2019	CI
15/19/15	Joben Bio-Medical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2018	CI

Director	Title	Age	Since
Wen Tien Huang CHM	Chairman	-	20/05/2010
Man Hsia Chia BRD	Director/Board Member	-	20/05/2010
Chao Yuan Kuo BRD	Director/Board Member	-	24/06/2011

JBM Share Price

Stocks

4193

TW0004193008

Biotechnology & Medical Research

Valuation: JBM

Latest news : JBM

Quotes and Performance

Managers and Directors: JBM

Other Biotechnology & Medical Research

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
JBM	+0.96%	+8.81%	-	-	2.1Cr
LONZA GROUP AG	-0.48%	+7.20%	-5.65%	+1.02%	4.62TCr
REVOLUTION MEDICINES, INC.	+2.19%	+11.71%	+393.31%	+580.42%	3.87TCr
IQVIA HOLDINGS INC.	+2.53%	+13.93%	+21.38%	-12.81%	3.19TCr
BEONE MEDICINES AG	+1.65%	+3.61%	+16.04%	+55.62%	3.11TCr
CELLTRION, INC.	-4.16%	-2.58%	+8.94%	+25.31%	2.38TCr
ASCENDIS PHARMA A/S	-0.32%	+12.96%	-	-	1.62TCr
MEDPACE HOLDINGS, INC.	+1.37%	+14.53%	+69.64%	+130.07%	1.51TCr
EUROFINS SCIENTIFIC SE	+1.00%	+10.30%	+13.31%	+20.31%	1.37TCr
IONIS PHARMACEUTICALS, INC.	+3.63%	+9.53%	+103.97%	+98.73%	1.34TCr
Average	+0.84%	+9.10%	+77.62%	+112.33%	2.3TCr
Weighted average by Cap.	+0.75%	+8.71%	+88.75%	+130.90%

	2017	2018
Net sales	55Cr 1.77TCr 49Cr 45Cr 42Cr 79Cr 5.23TCr 80Cr 538.18Cr 208.24Cr 2.58TCr 208.03Cr 203.49Cr 8.96TCr	19Cr 613.3Cr 17Cr 16Cr 15Cr 27Cr 1.82TCr 28Cr 186.91Cr 72Cr 897.04Cr 72Cr 71Cr 3.11TCr
Net income	6.07Cr 193.35Cr 5.32Cr 4.9Cr 4.59Cr 8.61Cr 572.2Cr 8.79Cr 59Cr 23Cr 282.8Cr 23Cr 22Cr 980.61Cr	-12Cr -393.11Cr -11Cr -9.97Cr -9.33Cr -17Cr -1.16TCr -18Cr -119.8Cr -46Cr -574.97Cr -46Cr -45Cr -1.99TCr
Net Debt	23.49L 7.49Cr 20.6L 18.98L 17.77L 33.33L 22Cr 34.02L 2.28Cr 88.29L 11Cr 88.2L 86.28L 38Cr	23Cr 722.72Cr 20Cr 18Cr 17Cr 32Cr 2.14TCr 33Cr 220.25Cr 85Cr 1.06TCr 85Cr 83Cr 3.67TCr